The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa

Vaccine

Volumn 31, Issue 47, 2013, Pages 5579-5584

  Andersson, M I ^a   Maponga, T G ^a   Ijaz, S ^b   Barnes, J ^a   Theron, G B ^a   Meredith, S A ^c   Preiser, W ^a   Tedder, R S ^b,d  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antenatal; HBV; HIV; Sub Saharan Africa; Virus escape

Indexed keywords

EFAVIRENZ; EPITOPE; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ARTICLE; CONTROLLED STUDY; EPIDEMIC; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MIXED INFECTION; MORBIDITY; MORTALITY; NONHUMAN; PERSISTENT VIRUS INFECTION; PHENOTYPE; PREGNANT WOMAN; PRIORITY JOURNAL; SOUTH AFRICA; VIRUS INFECTIVITY; VIRUS LOAD;

ANTENATAL; HBV; HIV; SUB-SAHARAN AFRICA; VIRUS ESCAPE;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS D; HIV INFECTIONS; HUMANS; MASS SPECTROMETRY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SOUTH AFRICA; VIRAL LOAD; YOUNG ADULT;

EID: 84886769293     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.028     Document Type: Article

References (33)

1. Hoffmann C.J., Thio C.L. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 2007, 7(6):402-409.
2. Gilson R.J., Hawkins A.E., Beecham M.R., Ross E., Waite J., Briggs M., et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997, 11(5):597-606.
3. Colin J.F., Cazals-Hatem D., Loriot M.A., Martinot-Peignoux M., Pharm B.N., Auperin A., et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 1999, 29(4):1306-1310.
4. Di Martino V., Thevenot T., Colin J.F., Boyer N., Martinot M., Degos F., et al. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology 2002, 123(6):1812-1822.
5. Puoti M., Torti C., Bruno R., Filice G., Carosi G. Natural history of chronic hepatitis B in co-infected patients. J Hepatol 2006, 44(1 Suppl):S65-S70.
6. Xu D.Z., Yan Y.P., Choi B.C., Xu J.Q., Men K., Zhang J.X., et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002, 67(1):20-26.
7. Burk R.D., Hwang L.Y., Ho G.Y., Shafritz D.A., Beasley R.P. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994, 170(6):1418-1423.
8. Botha J.F., Ritchie M.J., Dusheiko G.M., Mouton H.W., Kew M.C. Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection. Lancet 1984, 1(8388):1210-1212.
9. Whittle H.C., Bradley A.K., McLauchlan K., Ajdukiewicz A.B., Howard C.R., Zuckerman A.J., et al. Hepatitis B virus infection in two Gambian villages. Lancet 1983, 1(8335):1203-1206.
10. Department of Health 2008 National Antenatal Sentinel HIV and Syphilis Prevalence Survey, South Africa 2009, [accessed 08.07.13]. http://www.info.gov.za/view/DownloadFileAction%3Fid=1090.
11. Garson J.A., Grant P.R., Ayliffe U., Ferns R.B., Tedder R.S. Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. J Virol Methods 2005, 126(1-2):207-213.
12. Health Protection Agency. Recommended protocol for HBV genotyping and for antiviral resistance analysis. Available from: [accessed 29.11.12]. http://www.hpa.org.uk/ProductsServices/InfectiousDiseases/LaboratoriesAndReferenceFacilities/VirusReferenceDepartment/BloodBorneVirusesUnit/.
13. Tedder R.S., Rodger A.J., Fries L., Ijaz S., Thursz M., Rosenberg W., et al. The diversity and management of chronic hepatitis B virus infections in the United Kingdom: A wake-up call. Clin Infect Dis 2013, 56(7):951-960.
14. Ijaz S., Szypulska R., Andrews N., Tedder R.S. Investigating the impact of hepatitis B surface gene polymorphism on antigenicity using ex-vivo phenotyping. J Gen Virol 2012, 93(Pt. II):2473-2479.
15. Cohen K., van Cutsem G., Boulle A., McIlleron H., Goemaere E., Smith P.J., et al. Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis. J Antimicrob Chemother 2008, 61(2):389-393.
16. Hepatitis T.C.L. B and human immunodeficiency virus coinfection. Hepatology 2009, 49(5 Suppl):S138-S145.
17. Burnett R.J., Ngobeni J.M., Francois G., Hoosen A.A., Leroux-Roels G., Meheus A., et al. Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women. Int J STD AIDS 2007, 18(3):152-156.
18. Rouet F., Chaix M.L., Inwoley A., Msellati P., Viho I., Combe P., et al. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: the ANRS 1236 study. J Med Virol 2004, 74(1):34-40.
19. Ahmed S.D., Cuevas L.E., Brabin B.J., Kazembe P., Broadhead R., Verhoeff F.H., et al. Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. J Infect 1998, 37(3):248-251.
20. Msuya S.E., Mbizvo E.M., Hussain A., Sam N.E., Stray-Pedersen B. Seroprevalence of hepatitis B and C viruses among women of childbearing age in Moshi Urban, Tanzania. East Afr Med J 2006, 83(2):91-94.
21. Oshitani H., Kasolo F.C., Mpabalwani M., Mizuta K., Luo N.P., Suzuki H., et al. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. Trans R Soc Trop Med Hyg 1996, 90(3):235-236.
22. Andersson M.I., Maponga T.G., Ijaz S., Theron G., Preiser W., Tedder R.S. High HBV viral loads in HIV-infected pregnant women at a tertiary hospital, South Africa. J Acquir Immune Defic Syndr 2012, 60(4):e111-e112.
23. World Health Organisation Hepatitis B vaccines: WHO position paper. Wkly Epidemiol Rec 2009, 84(40):405-419.
24. Guidozzi F., Schoub B.D., Johnson S., Song E. Should pregnant urban south African women be screened for hepatitis B?. S Afr Med J 1993, 83(2):103-105.
25. Prozesky O.W., Szmuness W., Stevens C.E., Kew M.C., Harley E.J., Hoyland J.A., et al. Baseline epidemiological studies for a hepatitis B vaccine in trial in Kangwane. S Afr Med J 1983, 64(23):891-893.
26. Klingler C., Thoumi A.I., MrithinjayamV.S. Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique. Vaccine 2012, 31(1):252-259.
27. Shisana O., Rehle T., Simbayi L. South African National HIV prevalence, incidence and communication survey 2008, http://www.hsrcpress.ac.za/product.php?productid=2279&freedownload=1 [accessed 21.07.13].
28. Hsu H.Y., Chang M.H., Hsieh K.H., Lee C.Y., Lin H.H., Hwang L.H., et al. Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology 1992, 15(5):770-776.
29. Liu S., Zhang H., Gu C., Yin J., He Y., Xie J., et al. Association between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 2009, 101(15):1066-1082.
30. Carman W.F., Zanetti A.R., Karayiannis P., Waters J., Manzillo G., Tanzi E., et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990, 336(8711):325-329.
31. Benhamou Y., Bochet M., Thibault V., Di Martino V., Caumes E., Bricaire F., et al. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology 1999, 30(5):1302-1306.
32. Sheldon J., Ramos B., Garcia-Samaniego J., Rios P., Bartholomeusz A., Romero M., et al. Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity. J Acquir Immune Defic Syndr 2007, 46(3):279-282.
33. Clements C.J., Coghlan B., Creati M., Locarnini S., Tedder R.S., Torresi J. Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?. Bull World Health Organ 2010, 88(1):66-73.